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1 INTRODUCTION 
The severity and consequences of myocardial ischemia is influenced by 
several anatomical, pathophysiological, and pharmacological factors. 
Diversity of the clinical appearance of CAD is primarily determined by (1) 
variability of progression of coronary artery atherosclerosis, (2) different 
functional significance of apparently similar coronary stenoses, (3) 
influence of specific metabolic and pathophysiologic conditions of the heart 
on adaptation to myocardial ischemia, and (4) pharmacological 
modification of the ischemic response. Coronary angiography is still the 
most accepted standard means for assessing the progression of 
atherosclerotic plaque formation, however, due to its invasive nature, 
repeated cardiac catheterizations can not be a routine method for the follow-
up of progression of CAD. A reliable stress test, e.g DET would obviously 
be valuable for the non-invasive prediction of progression of CAD, and for 
the optimal timing of repeated catheterization in symptomatic patients with 
previously detected CAD. 
However, DET might be inferior to other non-invasive methods targeting a 
specific vessel segment in post-PCI cases of possible restenosis. 
Theoretically, CFR measurement by TEE can be used for a semi-invasive 
follow-up for functional evaluation and prediction of long-term success of 
PCI. Systematic use of STEE for follow-up of post-PCI patients can help us 
selecting subjects with significant restenosis and high-risk ischemia and 
referring them to a repeated invasive study. 
The diverse clinical appearance of CAD is resulted not only from the 
variable nature of atherosclerosis progression and/or restenosis process, but 
also from the individual differences in response of myocardium to ischemia. 
This is, at least in part, due to the preconditioned state of the myocardium to 
ischemia. One of the human models of ischemic preconditioning most 
frequently applied in humans is PCI, where, consecutive brief periods of 
balloon inflation provide an opportunity to perform and assess the effects of 
preconditioning. 
Although preconditioning provides a remarkable cardioprotection, its 
effectiveness is attenuated in some animal models of diseases, including 
hyperlipidemia, diabetes, nitrate tolerance, heart failure, and aging. Among 
these factors, little is known about the effects of hypercholesterolemia on 
preconditioning in humans. Not only short ischemic episodes, but 
additionally certain pharmacological agents can also precondition the 
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myocardium. This phenomenon is termed ‘pharmacological 
preconditioning’. There is strong evidence, that the protection associated 
with preconditioning involves the early release of bradykinin and the 
subsequent activation of bradykinin B2 receptors. The protective effect of 
intracoronary infusions of bradykinin, administered prior to angioplasty, has 
been described in patients with severe coronary artery disease. These results 
suggest that locally administered ACE inhibitors have beneficial effects 
against myocardial ischemia in both acute coronary syndromes and chronic 
conditions of ischemic heart disease.  
Overall, the aim of thesis was to determine the clinical value of different 
procedures in invasive cardiology for the accurate and case-specific 
assessment and mechanical or parmacological relief of myocardial ischemia 
in the variable environment of CAD progression and ischemia sensitivity. 
 
2 PRIMARY GOALS OF THE THESIS 
1. The great variability and the unpredictable nature of atherosclerosis 
progression makes difficult to plan the regular invasive follow-up of 
patients with borderline coronary artery stenoses and/or diffuse 
atherosclerotic disease. Two series of clinical investigations were 
performed to work out a less invasive follow-up strategy in patients 
with CAD. 
a) Analysis of the results of repeated dipyridamole-stress 
echocardiography to predict the angiographic progression of 
coronary artery disease. 
b) Repeated semi-invasive coronary flow velocity reserve 
measurements by transoesophageal echocardiography for 
prediction of restenosis following PCI. 
2. With the human experimental model of ischemic and pharmacologic 
preconditioning we intended to prove that 
a) The adaptive response of the myocardium to ischemia is attenuated 
by different pathologic states, eg. hypercholesterolemia. 
b) Pharmacologic stimuli – e.g. ACE inhibitor pretreatment – may 
have a potential for improving the protective effect of ischemic 
preconditioning. 
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3 METHODS 
3.1. Study populations and protocols 
3.1.1. Non-invasive prediction of angiographic progression of coronary 
artery disease by dipyridamole-stress echocardiography: A series of 60 
patients were selected for whom DET and diagnostic coronary angiography 
had been repeated over a period of 15 years. Echocardiograms and coronary 
angiograms were recorded and interpreted independently by separate 
reviewers blinded to the results of the other tests. 
3.1.2. The coronary flow velocity reserve measured by stress 
transoesophageal echocardiography evaluates the success of coronary 
interventions: The population of 31 patients underwent LAD-PCI including 
bare-metal stent implantation. STEE was performed on average 8±13 days 
before PCI and on average 5±4 weeks after it. A third control STEE 
examination was also performed, 33±20 weeks after the successful PCI. All 
patients were controlled and undergone telephone consultation 58±10 
months after PCI. 
3.1.3. The effect of hypercholesterolemia on anti-ischemic effect of 
preconditioning during coronary angioplasty: The investigations were 
carried out in single-vessel coronary disease patients elected for PCI. 
Following exclusion of patients not eligible for the study, 15-15 patients 
were classified into normocholesterolemic and hypercholesterolemic. 
3.1.4. Myocardial protection with enalaprilat in patients unresponsive to 
ischemic preconditioning during percutaneous coronary intervention: 
Patients referred for elective PCI with stable angina and single-vessel 
coronary artery disease were selected for the study. The 20 patients included 
in the investigation were randomly allocated to either the control group or 
the enalaprilat group, in such a way that each group contained 10 patients. 
3.2. Diagnostic and interventional methods applied in the studies 
3.2.1. Coronary angiography 
Diagnostic coronary arteriography was carried out with the use of 
standardized projections. All coronary arteriograms were reviewed and 
analysed visually by two independent observers. The stenosis was 
considered significant in the event of a lumen area reduction > 75%. For the 
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study to evaluate prediction of angiographic progression of coronary artery 
disease, for any given stenosis and both angiograms, QCA measurement 
was performed by an automatic edge-detection system. On the basis of a-
priori criteria, patients were defined as angiographic progressors if any 
progression of stenosis was detected visually and if there was any stenosis 
>30% for which >20% progression of stenosis was measured by 
quantitative coronary angiography. The extent of CAD was also evaluated 
by means of the Duke scoring system. 
3.2.2. PCI protocol 
A percutaneous femoral or transradial approach was used for PCI. The 
coronary artery lesion was crossed with PCI guidewire. Patients underwent 
repeated balloon inflations, with periods of reperfusion. In the 
preconditioning studies, completeness of the coronary occlusion was 
assessed by a short injection of contrast material. In the study to evaluate 
the protective effect of enalaprilate, a continuous intracoronary infusion of 
saline (control group; n = 10) or enalaprilat (enalaprilat group; n = 10) was 
started immediately after deflation of the first balloon occlusion using the 
guiding catheter. After cessation of the second inflation, the study protocol 
was terminated. 
3.2.3. Quantitative assessment of myocardial ischemia during PCI 
Myocardial ischemia was assessed by measurement of the intracoronary 
ST-segment elevation by lead C1 of the ECG monitoring system connected 
to the coronary guidewire. Intracoronary ECG, and intraaortic blood-
pressure signals were recorded online, and then every beat was evaluated by 
an independent physician in a blinded arrangement. The total ischemic 
burden was characterized by measuring the mean ST-segment deviation 
(mV) and the peak ST-segment elevation (mV). The dynamics of the 
evolution of ischemia was characterized with the time to reach 0.5 mV ST-
segment elevation. 
3.2.4. Transthoracic and stress transoesophageal echocardiography 
The left ventricular internal dimensions were measured by 2-dimensional 
directed M-mode transthoracic echocardiography. The ejection fraction was 
calculated by the method of Teichholz et al. TEE-derived CFR 
measurements were carried out according to the standard protocol proposed 
by Iliceto et al. The coronary flow waveform in the LAD was recorded by 
pulsed Doppler. Flow measurements were made under baseline conditions 
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and after the administration of 0.56 mg/kg dipyridamole during 4 minutes. 
The CFR was calculated as the ratio of the APV during hyperemia to the 
resting APV. 
3.2.4.1. DET protocol 
Two-dimensional echocardiographic and electrocardiographic monitoring 
were performed in combination with infusion of dipyridamole at an initial 
rate of 0.56 mg/kg over 4 min. Two-dimensional echocardiograms were 
continuously obtained. Echocardiographic diagnostic end point was the 
development of obvious echocardiographic positivity. Regional wall motion 
was assessed, and the wall-motion-score index was derived. According to 
DET criteria, progressors were defined according to the satisfaction of at 
least one of two criteria: (1) a negative result of DET in initial testing and a 
positive result of DET in second testing; (2) positive results both of initial 
and of second tests, with the latter having a peak WMSI 0.12 greater than 
that in the former. 
3.3. Statistical analysis 
Statistical analysis was performed by using analysis of variance or the two-
tailed Student's t test for paired data as appropriate. The unpaired t test was 
applied for between group comparisons. For dichotomous variables, 
Fisher’s exact test was used. Data are reported as means±standard deviation. 
Correlation of [kappa] indices was used when appropriate. The sensitivity, 
specificity and positive and negative predictive value were calculating using 
standard formulae. In the DET study, ROC analysis was performed to 
identify the stress-echocardiographic parameter providing the best accuracy. 
To establish the predictive power of the CFR early after PCI, ROC curve 
was constructed and the area under curve was reported. For the 
preconditioning studies, the effects of repeated occlusions were analyzed by 
RM-ANOVA. Confidence intervals in pairwise comparisons were adjusted 
to multiplications according to the Sidak formula. 
 
4 MAIN RESULTS 
4.1. Non-invasive prediction of angiographic progression of coronary 
artery disease by dipyridamole-stress echocardiography 
The coefficient of agreement (κ) with coronary angiography was poor for 
resting echocardiography (κ=0.144), moderately high for clinical variables 
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(κ=0.266), and substantial for stress echocardiography (κ=0.764). The 
concordance of stress-echocardiographic data with respect to coronary-
angiography progressors was found 89%. The remaining patients were 
‘non-progressors’ in terms of stress-echocardiographic criteria. An excellent 
rate of concordance was achieved with a positive DET response becoming 
negative (100%) and with a negative DET response becoming positive 
(95%). The concordance was 100% for patients for whom the peak 
variations in WMSI and DET were chosen post hoc on the basis of ROC 
analysis. Sensitivity of the ‘progressor-pattern’ of stress-echocardiography 
test for predicting progression of CAD was 87%, specificity was 93%, 
positive predictive value was 96%, negative predictive value was 77% and 
accuracy was 90%. 
4.2. Coronary flow velocity reserve measured by stress 
transoesophageal echocardiography evaluates the success of coronary 
interventions 
The CFR early after PCI was found to exhibit good prognostic value in 
predicting patients with reintervention (ROC area:78%, p<0.05). The 
CFR<1.87 was found to have optimal accuracy selected as cut-off value 
with 69% sensitivity and 86% specificity. From patients who required rePCI 
or CABG, two patients died: one of them from acute anterior myocardial 
infarction 29 months after the PCI. From group 2, only one patient had a 
non-fatal myocardial infarction 30 months after PCI, no other coronary 
events were found in this group. New coronary interventions were not 
performed within the 5-year follow-up in group 2 and after the rePCI or 
CABG in group 1; all living patients are clinically stable now. 
4.3. The effect of hypercholesterolemia on anti-ischemic effect of 
preconditioning during coronary angioplasty 
In the normocholesterolemic group, ST-segment elevation showed a 
continuous rise. Repeated occlusions resulted in lower ST-segment 
elevations, showing the anti-ischemic effect of preconditioning. In the 
hypercholesterolemic group, a rapid elevation of the ST segment was 
developed, which was not observed in the subsequent two occlusions. From 
45 to 120 s of the occlusions, there was no difference between ST-segment 
elevations. This shows that in hypercholesterolemic patients, 
preconditioning only slowed down the rapid onset of ischemia seen at the 
initial phase of the first occlusion but did not protect against the evolution 
of ST-segment elevation observed by the end of the occlusions. In 
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normocholesterolemic patients, we observed a significant decrease in time 
to normalization of the ST segment during repeated reperfusions, while in 
the hypercholesterolemic group, this time was significantly prolonged after 
all the three ischemic periods as compared to the normocholesterolemic 
group. 
4.4. Myocardial protection with enalaprilat in patients unresponsive to 
ischemic preconditioning during percutaneous coronary intervention 
In the control patients without drug treatment, both the magnitude of the 
peak ST-segment elevation and the time course of ischemia development 
were almost identical during the first and second balloon inflations. In 
contrast, in the patients infused with enalaprilat the peak ST-segment 
elevation was significantly less, and the time to reach the 0.5 mV elevation 
was significantly longer during the second than during the first occlusion. 
The total ischemic burden during the first and second balloon inflations 
were similar in the control group whereas in the enalaprilat group this was 
significantly lower during the second occlusion. 
 
5 DISCUSSION 
The main interests of these studies were to examine the variability of 
myocardial ischemia and its clinical appearance. This is manifested in the 
non-linear progression of coronary atherosclerosis, and in the limited 
predictability of post-PCI restenosis, as well. Another principal 
manifestation of this variability is the diverse adaptation capability of the 
myocardium to ischemia. 
5.1. Non-invasive quantification of myocardial ischemia to improve the 
timing of repeated cardiac catheterization. 
The first two of our studies proved that both DET and STEE can correctly 
predict the progression of native coronary artery disease or the restenosis 
process. Both of these non-invasive tests can be of great benefit for the 
invasive cardiologist to correctly assess the indication of repeated cardiac 
catheterization. 
Serial assessment of repeated DET results allows one to separate 
angiographic progressors and non-progressors efficiently. The unique 
feature of the present study is that coronary-angiography and stress-
echocardiography results were not only assessed horizontally, at one point 
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in time, comparing different patients, but at two different times, using each 
patient as his or her own control in order to assess individual variations in 
anatomic angiographic progression and results of functional stress testing. 
Our second study on STEE-derived CFR in the evaluation of the long-term 
success of LAD-PCI proved that the clinical state of patients with 
functionally successful PCI improved and these cases did not require further 
invasive procedures during a 5-year follow-up period. Patients whose 
condition required rePCI or CABG within half a year, CFR remained 
unchanged and two patients died during this follow-up period. The TEE–
CFR may serve as a noninvasive index of early postangioplasty restenosis. 
5.2. Limitation of ischemic preconditioning by hypercholesterolemia 
and pharmacological enhancement of myocardial ischemic adaptation 
Our results proved that in patients with hypercholesterolemia ischemic 
preconditioning is limited compared to those with normal cholesterol blood 
level. This observation is a partial explanation of the interindividual 
variability of preconditioning, however it must be considered clinically 
important, because this raise attention to the fact that hyperlipidemia is a 
“double” risk factor; not only that of coronary atherosclerosis, but for the 
severity of myocardial ischemia, as well. We have shown here for the first 
time in the literature that in hypercholesterolemic patients, there is a rapid 
elevation of ST segment during the initial phase of coronary occlsuion, a 
phenomenon not seen in normocholesterolemic patients. Our results further 
show that in hypercholesterolemic patients, repeated occlusions although 
abolished the initial rapid elevation of ST segment but did not attenuate the 
maximum ST-segment elevation, and failed to decrease the time to 
normalization of ST segment after balloon deflations when compared to 
normocholesterolemic patients. These results provide evidence that 
hypercholesterolemia enhances the evolution of myocardial ischemia on 
coronary occlusion and significantly inhibits the antiischemic effect of 
preconditioning in humans. It should be noted here that similarly to 
hypercholesterolemic patients, in patients with other diseases such as 
diabetes, heart failure, and aging, the time course of ischemia during PCI 
may also be altered that can be assessed by a beat-to-beat analysis of ST-
segment elevation.  
This variability of adaptive response to ischemia of myocardium 
emphasizes the importance of therapeutic methods improving the efficacy 
of ischemic preconditioning. The last phase of our research investigated the 
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therapeutic aspects of the diversity in ischemic preconditioning. We 
attempted to decrease the variability of myocardial adaptation to ischemia 
by pharmacological potentiation of the ischemic preconditioning in patients 
undergoing PCI. The results of this study proved that the myocardium of 
patients with limited ischemic preconditioning can still be protected by 
combination of the short ischemic episodes with intracoronary enalaprilate 
infusion. 
The finding of this study supports our previous observation that in patients 
with severe coronary artery disease who undergo elective PCI, a single brief 
(2-min) period of balloon inflation is not sufficient to give rise to significant 
improvements in the intracoronary ST-segment changes that occur during a 
subsequent, similar period of balloon inflation. We have now demonstrated 
for the first time that the administration of enalaprilat to such patients 
during PCI does induce protection, as revealed by significant reductions in 
the mean and peak ST-segment elevation and the onset of ischemic changes 
during the second coronary artery occlusion. We consider, that this timing 
of the drug administration could be of particular importance in everyday 
clinical practice, since, a variable degree of myocardial ischemia is already 
present in a substantial proportion of patients with acute coronary 
syndromes who are referred for emergency PCI. In this patient subset, 
persistence of ischemic symptoms demonstrate considerably jeopardized 
state of the myocardium and, limited preconditioning effect of the 
sequential short ischemic episodes. Our results served indirect information 
that in these high-risk patients – particularly in those with slow flow and no-
reflow phenomenon - the administration of intracoronary enalaprilat can 
still be cardioprotective. 
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6 CONCLUSIONS (NEW OBSERVATIONS) 
1. Spontaneous evolution of angiographically assessed coronary artery 
disease can usefully be monitored non-invasively through variations in 
serial dipyridamole-stress echocardiography. This technique is highly 
feasible, widely available, of low cost, employing non-ionizing energy. This 
application can further contribute to the expanding use of stress 
echocardiography in the cardiological practice. 
2. CFR is significantly higher early after functionally successful PCI as 
assessed by STEE. CFR of patients with successful LAD-PCI increased to 
>2 and they suffered no major clinical events during the follow-up. In 
contrast, in those a priori had a low CFR and no improvement after PCI, 
further invasive procedures and major events did occur during this period. 
3. Hypercholesterolemia attenuates the anti-ischemic effect of 
preconditioning, accelerates the evolution of myocardial ischemia, and 
delays the recovery from ischemia on reperfusion in patients undergoing 
elective PCI. 
4. There is a population of patients with severe coronary artery disease and 
assigned to elective PCI in whom a brief period of coronary occlusion fails 
to produce protection against the consequences of a subsequent, similar 
period of ischemia. We have shown that, in these patients who seem to be 
unresponsive to this initial preconditioning ischemia, administration of 
intracoronary enalaprilat during the procedure can still elicit adequate 
protection. 
 
ABBREVIATIONS 
ACE:  angiotensin converting enzyme 
APV: average peak diastolic flow velocity 
ATP:  adenosine triphosphate 
CABG:  coronary artery bypass graft 
CAD:  coronary artery disease 
CFR:  coronary flow reserve 
DET:  dipyridamole-stress echocardiography 
DNA:  deoxyribonucleic acid 
ECG:  electrocardiogram 
LAD:  left anterior descending 
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LV:  left ventricle 
LVEF:  left ventricular ejection fraction 
NYHA:  New York Heart Association 
PCI:  percutaneous coronary intervention 
RM-ANOVA:  repeated measures analysis of variance 
ROC:  receiver-operating characteristics 
STEE:  stress transesophageal echocardiography 
TEE:  transesophageal echocardiography 
WMSI:  wall-motion-score index 
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